Noradrenaline in the aging brain: Promoting cognitive reserve or accelerating Alzheimer's disease?
- PMID: 34099360
- PMCID: PMC8292227
- DOI: 10.1016/j.semcdb.2021.05.013
Noradrenaline in the aging brain: Promoting cognitive reserve or accelerating Alzheimer's disease?
Abstract
Many believe that engaging in novel and mentally challenging activities promotes brain health and prevents Alzheimer's disease in later life. However, mental stimulation may also have risks as well as benefits. As neurons release neurotransmitters, they often also release amyloid peptides and tau proteins into the extracellular space. These by-products of neural activity can aggregate into the tau tangle and amyloid plaque signatures of Alzheimer's disease. Over time, more active brain regions accumulate more pathology. Thus, increasing brain activity can have a cost. But the neuromodulator noradrenaline, released during novel and mentally stimulating events, may have some protective effects-as well as some negative effects. Via its inhibitory and excitatory effects on neurons and microglia, noradrenaline sometimes prevents and sometimes accelerates the production and accumulation of amyloid-β and tau in various brain regions. Both α2A- and β-adrenergic receptors influence amyloid-β production and tau hyperphosphorylation. Adrenergic activity also influences clearance of amyloid-β and tau. Furthermore, some findings suggest that Alzheimer's disease increases noradrenergic activity, at least in its early phases. Because older brains clear the by-products of synaptic activity less effectively, increased synaptic activity in the older brain risks accelerating the accumulation of Alzheimer's pathology more than it does in the younger brain.
Keywords: Aging; Alzheimer’s disease; Glutamatergic activity; Locus coeruleus.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Figures

Similar articles
-
The Locus Coeruleus - Noradrenaline system: Looking into Alzheimer's therapeutics with rose coloured glasses.Biomed Pharmacother. 2022 Jul;151:113179. doi: 10.1016/j.biopha.2022.113179. Epub 2022 May 27. Biomed Pharmacother. 2022. PMID: 35676784 Review.
-
Neural substrates of cognitive reserve in Alzheimer's disease spectrum and normal aging.Neuroimage. 2019 Feb 1;186:690-702. doi: 10.1016/j.neuroimage.2018.11.053. Epub 2018 Nov 29. Neuroimage. 2019. PMID: 30503934
-
Tau pathology and cognitive reserve in Alzheimer's disease.Neurobiol Aging. 2017 Sep;57:1-7. doi: 10.1016/j.neurobiolaging.2017.05.004. Epub 2017 May 10. Neurobiol Aging. 2017. PMID: 28577411
-
Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.Brain Behav Immun. 2019 Nov;82:264-278. doi: 10.1016/j.bbi.2019.08.194. Epub 2019 Aug 30. Brain Behav Immun. 2019. PMID: 31476414
-
Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice.Exp Gerontol. 2000 Sep;35(6-7):831-41. doi: 10.1016/s0531-5565(00)00149-2. Exp Gerontol. 2000. PMID: 11053674 Review.
Cited by
-
Selective Noradrenaline Depletion in the Neocortex and Hippocampus Induces Working Memory Deficits and Regional Occurrence of Pathological Proteins.Biology (Basel). 2023 Sep 21;12(9):1264. doi: 10.3390/biology12091264. Biology (Basel). 2023. PMID: 37759663 Free PMC article.
-
Norepinephrine May Oppose Other Neuromodulators to Impact Alzheimer's Disease.Int J Mol Sci. 2021 Jul 8;22(14):7364. doi: 10.3390/ijms22147364. Int J Mol Sci. 2021. PMID: 34298984 Free PMC article.
-
Heart rate and breathing effects on attention and memory (HeartBEAM): study protocol for a randomized controlled trial in older adults.Trials. 2024 Mar 15;25(1):190. doi: 10.1186/s13063-024-07943-y. Trials. 2024. PMID: 38491546 Free PMC article.
-
Autonomic function predicts cognitive decline in mild cognitive impairment: Evidence from power spectral analysis of heart rate variability in a longitudinal study.Front Aging Neurosci. 2022 Sep 15;14:886023. doi: 10.3389/fnagi.2022.886023. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36185491 Free PMC article.
-
Lower novelty-related locus coeruleus function is associated with Aβ-related cognitive decline in clinically healthy individuals.Nat Commun. 2022 Mar 23;13(1):1571. doi: 10.1038/s41467-022-28986-2. Nat Commun. 2022. PMID: 35322012 Free PMC article.
References
-
- Robertson IH, A noradrenergic theory of cognitive reserve: implications for Alzheimer’s disease. Neurobiology of aging, 2013. 34(1): p. 298–308. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials